Articles
Articles
Reference articles published on this site.
- September 20, 2026How Much Does Tesamorelin Cost? Peptide Pricing in 2026Tesamorelin costs $115 per 10 mg vial at HEEZ Research, or $11.50/mg; 30 days at the 2 mg trial amount takes 6 vials, $690. 2026 price table.
- September 20, 2026Where to Buy Tesamorelin Peptide in 2026Tesamorelin is sold two ways: as the prescription drug Egrifta and as research material, $115 per 10 mg vial. What differs, and what a COA must show.
- September 20, 2026KLOW Peptide for Sale: Price and Buying Guide for 2026KLOW peptide sells for $145 per 80 mg vial at HEEZ Research, or $1.81/mg. What the blend contains, what a blend COA has to prove, and how to compare listings.
- September 20, 2026What Is KLOW Peptide? The Four-Component Blend ExplainedKLOW is a four-peptide research blend sold as an 80 mg vial. What the name means, why the powder is blue, and what the evidence does and does not cover.
- September 17, 2026Where to Buy Retatrutide Peptide in 2026Retatrutide has no pharmacy channel anywhere; it sells only as research material, $100 per 10 mg vial and $195 per 20 mg ($9.75/mg) as of September 2026.
- September 15, 2026How Much Does Retatrutide Cost? Peptide Pricing in 2026Retatrutide costs $9.75/mg (20 mg vial) at HEEZ Research; a 4-week block at 8 mg/week runs $390. Full per-mg price table for 2026.
- September 14, 2026GLP-1 Receptor Agonist Mechanism: cAMP, Glucose, Beta CellsGLP-1 receptor agonists bind a class B1 GPCR on beta cells, raise cAMP and potentiate insulin release only above normal glucose. ECC5004 IC50: 2.4 nM.
- September 14, 2026Insulin Structure: A6-A11, A7-B7 and A20-B19 DisulfidesInsulin's A-chain and B-chain are joined by three disulfide bonds: A6-A11 inside the A-chain, plus A7-B7 and A20-B19 between the chains.
- September 13, 2026GLP-1 Weight Loss Trial Data: 68-Week Results by DrugSemaglutide 2.4 mg cut body weight 16.0% at 68 weeks vs 5.7% placebo in STEP 3; across 47 GLP-1 trials the pooled mean loss is 4.57 kg.
- September 13, 2026Peptide Oral Bioavailability Barriers and the 100x Dose GapMost peptides reach under 1% oral bioavailability, so an oral dose must run over 100x a fully absorbed route. Barriers, stage by stage.
- September 12, 2026FDA Approved Peptide Drugs: 2 PDCs and Why Lists DifferFDA approves products, not classes, so no official peptide list exists. Two peptide-drug conjugates are approved for cancer; counts vary by agency.
- September 10, 2026Peptide vs Small Molecule Drugs: Route, Dose, Trial SizeNine biologics and oral tofacitinib share one Cochrane network of 32,874 patients (ACR50 RR 2.71); atogepant's arms span 12-fold in total mg.